Literature DB >> 18273560

Remote renal preconditioning-induced cardioprotection: a key role of hypoxia inducible factor-prolyl 4-hydroxylases.

Ravi Kant1, Vishal Diwan, Amteshwar Singh Jaggi, Nirmal Singh, Dhandeep Singh.   

Abstract

Remote preconditioning is a unique phenomenon in which brief episodes of ischemia and reperfusion to remote organ protect the target organ against sustained ischemia-reperfusion (I/R)-induced injury. Protective effects of remote renal preconditioning (RRPC) are well established in heart, but their mechanisms still remain to be elucidated. So, the present study was designed to investigate the possible role of oxygen-sensing hypoxia inducible factor-prolyl 4-hydroxylases (HIF-P4Hs) in RRPC-induced cardioprotection in rats. Remote renal preconditioning was performed by four episodes of 5 min renal artery occlusion and reperfusion. Isolated rat hearts were perfused on Langendorff apparatus and were subjected to global ischemia for 30 min followed by 120 min reperfusion. The levels of lactate dehydrogenase (LDH) and creatine kinase (CK) were measured in coronary effluent to assess the degree of myocardial injury. Extent of myocardial infarct size and coronary flow rate was also measured. Ethyl 3,4-dihydroxybenzoate (EDHB) and alpha-ketoglutarate (alpha-KG) were employed as HIF-P4Hs inhibitor and activator, respectively. Diethyldithiocarbamic acid (DDCA) was employed as NFkB inhibitor. Remote renal preconditioning prevented I/R-induced myocardial injury and produced cardioprotective effects. Pharmacological preconditioning with EDHB (100 mg kg(-1) i.p.) mimicked the cardioprotective effects of RRPC. However, alpha-KG (200 mg kg(-1) i.p.) and DDCA (150 mg kg(-1) i.p.) abolished cardioprotective effects of RRPC and EDHB. So, it may be concluded that inhibition of HIF-P4H has a key role in RRPC-induced cardioprotection. Further, remote preconditioning-induced HIF-P4H inhibition may have triggered a transduction pathway involving activation of NFkB.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18273560     DOI: 10.1007/s11010-008-9717-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

1.  Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity.

Authors:  Eoin P Cummins; Edurne Berra; Katrina M Comerford; Amandine Ginouves; Kathleen T Fitzgerald; Fergal Seeballuck; Catherine Godson; Jens E Nielsen; Paul Moynagh; Jacques Pouyssegur; Cormac T Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-17       Impact factor: 11.205

2.  Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury.

Authors:  Ramesh Natarajan; Fadi N Salloum; Bernard J Fisher; Rakesh C Kukreja; Alpha A Fowler
Journal:  Circ Res       Date:  2005-11-23       Impact factor: 17.367

3.  Reduction of collagen production in keloid fibroblast cultures by ethyl-3,4-dihydroxybenzoate. Inhibition of prolyl hydroxylase activity as a mechanism of action.

Authors:  T Sasaki; K Majamaa; J Uitto
Journal:  J Biol Chem       Date:  1987-07-05       Impact factor: 5.157

4.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

5.  HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation.

Authors:  Ramzi Ockaili; Ramesh Natarajan; Fadi Salloum; Bernard J Fisher; Drew Jones; Alpha A Fowler; Rakesh C Kukreja
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-04-01       Impact factor: 4.733

6.  Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system.

Authors:  Ambreena Siddiq; Issam A Ayoub; Juan C Chavez; Leila Aminova; Sapan Shah; Joseph C LaManna; Stephanie M Patton; James R Connor; Robert A Cherny; Irene Volitakis; Ashley I Bush; Ingrid Langsetmo; Todd Seeley; Volkmar Gunzler; Rajiv R Ratan
Journal:  J Biol Chem       Date:  2005-10-13       Impact factor: 5.157

7.  Myocardial protection by remote preconditioning: the role of nuclear factor kappa-B p105 and inducible nitric oxide synthase.

Authors:  Guohu Li; Fausto Labruto; Allan Sirsjö; Fei Chen; Jarle Vaage; Guro Valen
Journal:  Eur J Cardiothorac Surg       Date:  2004-11       Impact factor: 4.191

8.  Alpha-ketoglutarate stimulates procollagen production in cultured human dermal fibroblasts, and decreases UVB-induced wrinkle formation following topical application on the dorsal skin of hairless mice.

Authors:  Eui Dong Son; Gyu Ho Choi; Hyaekyoung Kim; Byoungseok Lee; Ih Seoup Chang; Jae Sung Hwang
Journal:  Biol Pharm Bull       Date:  2007-08       Impact factor: 2.233

9.  Cardioprotection at a distance: mesenteric artery occlusion protects the myocardium via an opioid sensitive mechanism.

Authors:  Hemal H Patel; Jeannine Moore; Anna K Hsu; Garrett J Gross
Journal:  J Mol Cell Cardiol       Date:  2002-10       Impact factor: 5.000

10.  Spontaneous ischemic events in the brain and heart adapt the hearts of severely atherosclerotic mice to ischemia.

Authors:  Shinichi Tokuno; Kazuhiro Hinokiyama; Kumi Tokuno; Christian Löwbeer; Lars-Olof Hansson; Guro Valen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-06-01       Impact factor: 8.311

View more
  19 in total

1.  An Argonaute 2 switch regulates circulating miR-210 to coordinate hypoxic adaptation across cells.

Authors:  Andrew Hale; Changjin Lee; Sofia Annis; Pil-Ki Min; Reena Pande; Mark A Creager; Colleen G Julian; Lorna G Moore; S Alex Mitsialis; Sarah J Hwang; Stella Kourembanas; Stephen Y Chan
Journal:  Biochim Biophys Acta       Date:  2014-06-28

Review 2.  Hypoxia inducible factor 1 (HIF-1) and cardioprotection.

Authors:  Demet Tekin; Ali D Dursun; Lei Xi
Journal:  Acta Pharmacol Sin       Date:  2010-08-16       Impact factor: 6.150

3.  Investigating the involvement of TRPV1 ion channels in remote hind limb preconditioning-induced cardioprotection in rats.

Authors:  Puneet Kaur Randhawa; Amteshwar Singh Jaggi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-10-17       Impact factor: 3.000

4.  Signal mechanism activated by erythropoietin preconditioning and remote renal preconditioning-induced cardioprotection.

Authors:  Vishal Diwan; Ravi Kant; Amteshwar Singh Jaggi; Nirmal Singh; Dhandeep Singh
Journal:  Mol Cell Biochem       Date:  2008-06-05       Impact factor: 3.396

5.  Gadolinium and ruthenium red attenuate remote hind limb preconditioning-induced cardioprotection: possible role of TRP and especially TRPV channels.

Authors:  Puneet Kaur Randhawa; Amteshwar Singh Jaggi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-04-27       Impact factor: 3.000

6.  Possible role of thromboxane A2 in remote hind limb preconditioning-induced cardioprotection.

Authors:  Roohani Sharma; Puneet Kaur Randhawa; Nirmal Singh; Amteshwar Singh Jaggi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-11-03       Impact factor: 3.000

7.  Prolyl 4 hydroxylase: a critical target in the pathophysiology of diseases.

Authors:  Ravi Kant; Anjana Bali; Nirmal Singh; Amteshwar Singh Jaggi
Journal:  Korean J Physiol Pharmacol       Date:  2013-04-10       Impact factor: 2.016

8.  Remote ischemic conditioning: from bench to bedside.

Authors:  Shiang Yong Lim; Derek John Hausenloy
Journal:  Front Physiol       Date:  2012-02-20       Impact factor: 4.566

Review 9.  Hypoxia-inducible factors and the prevention of acute organ injury.

Authors:  Samuel N Heyman; Seymour Rosen; Christian Rosenberger
Journal:  Crit Care       Date:  2011-03-22       Impact factor: 9.097

Review 10.  Novel perspectives on the PHD-HIF oxygen sensing pathway in cardioprotection mediated by IPC and RIPC.

Authors:  Silvia Martin-Puig; Daniel Tello; Julián Aragonés
Journal:  Front Physiol       Date:  2015-05-20       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.